Title: A Histomorphological Study of Carcinoma Endometrium Conducted in a Tertiary Care Centre

Authors: Dr Resmi Rajeev, Dr Jyothi C R

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i11.78

Abstract

Introduction: Endometrial carcinoma is the second most common malignant tumor of female genital system in India and its incidence is increasing globally. Histological variants include endometrioid carcinoma, serous carcinoma, mucinous adenocarcinoma, clear cell carcinoma, mixed adenocarcinoma and others. Histopathologic prognostic parameters include tumor type, depth of invasion, lymphovascular involvement, FIGO grade and stage.

Materials and Method: A cross sectional study was conducted in the department of Pathology, Government medical college, Thrissur, during a period of 18months. Gross examination and morphological assessment of 37 cases of carcinoma endometrium were done.  Study was approved by the institutional ethical committee.

Result: 83.8% of endometrial carcinomas were endometrioid type, 16.2% were nonendometrioid type. 77.42%, 16.13% and 6.45% of endometrioid carcinomas were grade I, grade II and grade III respectively. 64.86% of endometrial cancers were stage I tumors. Glandular pattern was the predominant pattern (54.1%). 51.4% cases showed invasion less than half of myometrium. Prominent lymphocytic infiltrate was seen in 29.73% cases. Lymphovascular emboli were seen in 10.8% cases. Mitosis was ≤5 in 86.5% cases.

Conclusion: Most cases of endometrial carcinomas were of endometrioid type, with a predominance of grade I tumors. Majority of endometrial carcinomas belonged to FIGO stage Ia.

Keywords: Endometrial carcinoma, uterine cancer, endometrioid carcinoma, serous carcinoma

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359-E386.
  2. Buhtoiarova T, Brenner C, Singh M. Endometrial Carcinoma. American Journal of Clinical Pathology. 2015;145(1):8-21.
  3. Yeramian A, Moreno-Bueno G, Dolcet X, Catasus L, Abal M, Colas E et al. Endometrial carcinoma: molecular alterations involved in tumor development and progression. Oncogene. 2012;32(4):403-413.
  4. Matias-GuiuXPrat J. Molecular pathology of endometrial carcinoma. Histopathology. 2012;62(1):111-123.
  5. Kurman R, Carcangiu M, Herrington C, Young R (eds.). WHO Classification of Tumours of Female Reproductive Organs. 4thIARC. 2014.
  6. Indu M, Gayatri R, Julian A, Rekha P, Elizabeth V. Estrogen and Progesterone Receptor Expression in Endometrioid Endometrial Carcinomas: A Clinicopat-hological Study. MEJC. 2014; 5(2): 67-73.

Corresponding Author

Dr Resmi Rajeev

Senior Resident, Department of Pathology

Government Medical College, Thrissur, Kerala, India

Mobile no: 8281675204. Email: This email address is being protected from spambots. You need JavaScript enabled to view it.